This opportunity invites research applications for projects that support preclinical development of lead candidate therapeutics or diagnostics against NIAID Category A, B, or C priority agents. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant.
The full list of NIAID Category A, B, or C priority pathogens and toxins can be found here: http://www.niaid.nih.gov/TOPICS/BIODEFENSERELATED/BIODEFENSE/Pages/CatA.aspx
Applicable pathogens include: Burkholderia pseudomallei, Toxoplasma gondii, dengue, Japanese encephalitis virus, Chikungunya, tuberculosis, salmonella, E. coli and others.
Budgets for direct costs of up to $750,000 per year may be requested. In addition, applicants may request up to a total of $300,000 for major equipment in the first year of the award to ensure that research aims can be met and biohazards can be contained. The maximum period is 5 years.
The application deadline is 24 May 2012. A letter of intent is required by 24 April 2012.
For more information, see:
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-017.html
TropMed Sponsored Research Funding Opportunities: this blog is designed to alert TropMed researchers to funding opportunities to support their research. The Research Administration Unit of the Office of Research Services (ORS) is here to help staff members with all application, grant management, and post-grant processes. Please contact Mr. Paul Adams or Mr. Oiko Tacusalme on ext. 1332 for more information, or to express interest in any of these grant opportunities.
